BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23460638)

  • 1. Advances in the treatment of late stage melanoma.
    Walkington LA; Lorigan P; Danson SJ
    BMJ; 2013 Mar; 346():f1265. PubMed ID: 23460638
    [No Abstract]   [Full Text] [Related]  

  • 2. [New treatments for metastatic melanoma: a first hope].
    Robert C; Mateus C
    Rev Prat; 2011 Nov; 61(9 Suppl):S1-2. PubMed ID: 22338196
    [No Abstract]   [Full Text] [Related]  

  • 3. Meeting report from the Third Global Workshop on Melanoma.
    Agarwala SS; di Pietro A; Flaherty KT; Garbe C; Grob JJ; Kashani-Sabet M; Kirkwood JM; Leachman S; Messina J; O'Day S; Ribas A; Sondak V
    Pigment Cell Melanoma Res; 2010 Oct; 23(5):e1-7. PubMed ID: 20718940
    [No Abstract]   [Full Text] [Related]  

  • 4. The conquest of melanoma by immunotherapy.
    Lejeune FJ
    Melanoma Res; 2015 Oct; 25(5):373-5. PubMed ID: 26173006
    [No Abstract]   [Full Text] [Related]  

  • 5. Melanoma and immunotherapy.
    Eggermont AM; Schadendorf D
    Hematol Oncol Clin North Am; 2009 Jun; 23(3):547-64, ix-x. PubMed ID: 19464602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guidelines for stage I to III melanoma].
    Guillot B; Dalac S; Denis M; Dupuy A; Emile JF; De La Fouchardiere A; Hindie E; Jouary T; Lassau N; Mirabel X; Piperno Neumann S; De Raucourt S; Vanwijck R
    Bull Cancer; 2016 Sep; 103(9):743-52. PubMed ID: 27456259
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic treatment of metastatic melanoma: new approaches.
    Hamid O; Boasberg PD; Rosenthal K; O'Day SJ
    J Surg Oncol; 2011 Sep; 104(4):425-9. PubMed ID: 21858838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future directions of molecularly targeted therapies and immunotherapies for melanoma.
    Miller DM; Flaherty KT; Tsao H
    Semin Cutan Med Surg; 2014 Jun; 33(2):60-7. PubMed ID: 25085663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma: from darkness to promise.
    Gasent Blesa JM; Grande Pulido E; Alberola Candel V; Provencio Pulla M
    Am J Clin Oncol; 2011 Apr; 34(2):179-87. PubMed ID: 20498590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An incidental finding.
    Menon SK
    J Fam Pract; 2013 Nov; 62(11):655-9. PubMed ID: 24288711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape.
    Levine O; Devji T; Xie F
    Immunotherapy; 2017 Mar; 9(5):375-378. PubMed ID: 28357918
    [No Abstract]   [Full Text] [Related]  

  • 12. Is it good or bad to find a BRAF mutation?
    Flaherty KT
    J Clin Oncol; 2011 Apr; 29(10):1229-30. PubMed ID: 21343552
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting oncogenic drivers and the immune system in melanoma.
    McArthur GA; Ribas A
    J Clin Oncol; 2013 Feb; 31(4):499-506. PubMed ID: 23248252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic therapy for metastatic malignant melanoma--from deeply disappointing to bright future?
    Lorigan P; Eisen T; Hauschild A
    Exp Dermatol; 2008 May; 17(5):383-94. PubMed ID: 18312390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic diversity and immunological characteristics of malignant melanoma: the therapeutic spectrum].
    Doma V; Gulya E
    Orv Hetil; 2015 Apr; 156(15):583-91. PubMed ID: 25845317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No longer an untreatable disease: how targeted and immunotherapies have changed the management of melanoma patients.
    Girotti MR; Saturno G; Lorigan P; Marais R
    Mol Oncol; 2014 Sep; 8(6):1140-58. PubMed ID: 25178978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma.
    Benson C; Gore ME
    Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
    [No Abstract]   [Full Text] [Related]  

  • 18. A new era in the treatment of melanoma: from biology to clinical practice.
    Márquez-Rodas I; Martín Algarra S; Avilés Izquierdo JA; Custodio Cabello S; Martín M
    Clin Transl Oncol; 2011 Nov; 13(11):787-92. PubMed ID: 22082642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for Melanoma.
    Glitza Oliva IC; Alqusairi R
    Adv Exp Med Biol; 2018; 995():43-63. PubMed ID: 30539505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma treatment's changing landscape.
    Jenks S
    J Natl Cancer Inst; 2014 Jun; 106(6):dju176. PubMed ID: 24907389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.